Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 1 - 10 of 31 results
-
A Phase 3, Randomized, Open-label, Study to Assess the Immunogenicity and Safety of IVX-A12 when Co-administered with a Licensed Influenza Vaccine
Date:
01/01/2025Lead Investigators:
-
Long-Term Follow-up of an open-label single-arm phase IIb study of F901318
Date:
12/02/2024Topics:
Lead Investigators:
-
A Multicenter, Randomized, Double-Blind, Placebo controlled Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Participants living with Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection on Antiretroviral Treatment
Date:
12/01/2024Topics:
Lead Investigators:
-
A5391: Doravirine for Persons with Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide (The Do IT Study)
Date:
11/27/2023Topics:
Lead Investigators:
-
Structured Peer-delivered ART and Reentry Community Strategy (SPARCS) to overcome barriers to HIV care continuity during community reentry from incarceration in South Africa
Date:
09/01/2023Locations:
Lead Investigators:
-
EVOLVE: Emetine for Viral Outbreaks, A Double Blind Randomized Controlled Clinical Trial
Date:
06/01/2023Topics:
Lead Investigators:
-
Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes
Date:
05/25/2023Locations:
Lead Investigators:
-
Olorofim for Invasive Fungal Infections PhIII
Date:
01/03/2023Topics:
Lead Investigators:
-
AZD5156/AZD3152 mAbs for Covid-19 Prophylaxis in Immunocompromised Patients
Date:
01/01/2023Locations:
Lead Investigators:
-
A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFNa in Subjects with Chronic Hepatitis B Virus Infection
Date:
12/02/2022Topics:
Lead Investigators: